Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valproic Acid in Progressive Supranuclear Palsy
NCT00385710Phase 2Completed
- Sponsor
- CHU de Nantes
- Start
- Nov 2006
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in progressive supranuclear palsy (PSP) comparing valproic acid with Placebo (2 arms). Primary endpoint: Progressive Supranuclear Palsy Rating Scale. Started Nov 2006; status: completed.
02
Drugs
valproic acid
03
Conditions
progressive supranuclear palsy (PSP)
Beyond the preview
Go deeper on NCT00385710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00385710.